The ecosystem surrounding the pharmaceutical industry has become intertwined and complex, leading to noncompliance. Learn a path forward to bring transparency and integrity to these critical programs.
Eyebrow text
In 2019, total drug discounts reached $175 billion. According to our estimates, at least 5% are noncompliant… adding up to nearly $9 billion in lost revenue for manufacturers in 2019 alone.
Kalderos platform solutions enable manufacturers to identify and prevent noncompliance, ensuring the right discount to the right party on the right transaction®.
How can we get a big picture view of the unknown levels of drug discount program noncompliance?
In this recorded webinar event, Micah Litow, Kalderos President & COO and Scott Johnsen, Kalderos VP of Product, dive deep into the challenges faced by drug manufacturers looking to identify costly duplicate discounts.
Together with Kalderos Customer Success Director Vishali Amin, they'll explore the murky scale of noncompliance and reveal the tech-enabled solutions from Kalderos that are shining a light during this critical moment for drug discount program integrity.
Covered in this webinar:
See how Kalderos is focused on a future where gathering, sharing and analyzing data becomes a lot easier in our 2022 annual report.
We’ll show you how Kalderos 340B Pay facilitates easy exchange and validation of claims level data for 340B contract pharmacy dispenses, enabling holistic visibility across discount programs to identify more noncompliance.
You’ll see firsthand how greater clarity around 340B contract pharmacy dispenses enables you to ensure the discount is paid promptly to the healthcare provider, and respond with confidence to duplicate MDRP or commercial rebate claims.
Every drug manufacturer has unique needs. A member of our team will work with you one-on-one to assess how Kalderos’ Drug Discount Management platform can work for you.
We’ll show you how Kalderos 340B Pay facilitates easy exchange and validation of claims level data for 340B contract pharmacy dispenses, enabling holistic visibility across discount programs to identify more noncompliance.
You’ll see firsthand how greater clarity around 340B contract pharmacy dispenses enables you to ensure the discount is paid promptly to the healthcare provider, and respond with confidence to duplicate MDRP or commercial rebate claims.
Every drug manufacturer has unique needs. A member of our team will work with you one-on-one to assess how Kalderos’ Drug Discount Management platform can work for you.
By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.
By submitting this form, I agree that Kalderos.com may contact me at the email address or phone number above to tell me about its services.
By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.
By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris commodo euismod eros eget finibus. Ut vestibulum ex sed condimentum dictum. Cras purus massa, volutpat at nunc sed, commodo vestibulum tellus.
Kalderos helps manufacturers:
Utilize our interactive interface to manage your drug discount programs and track claims to ensure the right discount to the right party on the right transaction.
Only Kalderos has a multi-sided tech-enabled platform that connects manufacturers, providers and states, allowing all to benefit from shared data transparency.
Only Kalderos has a multi-sided tech-enabled platform that connects manufacturers, providers and states, allowing all to benefit from shared data transparency.
In 2019, total drug discounts reached $175 billion. According to our estimates, at least 5% are noncompliant… adding up to nearly $9 billion in lost revenue for manufacturers in 2019 alone.
Kalderos platform solutions enable manufacturers to identify and prevent noncompliance, ensuring the right discount to the right party on the right transaction®.
tools built on our platform
tools built on our platform
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce viverra ipsum quis pellentesque malesuada.
The 2022 annual report is titled "Conquering the 'Great Unknown': Connecting the data gaps that keep us from knowing the true price of drugs." Read the Kalderos 2022 annual report now, or download it to read later.
Visit Kalderos’ help center for assistance with your Kalderos account.